stockrow
Friday 6 November 2026
Export BAX’s income statement to Excel — free account
Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.
- Revenue
- +4.97%
- EPS
- +731.9%
- Free cash flow
- +255.6%
- Total debt
- −9.48%
Quarter to September 2026, against a year earlier
25.57
0.93
−3.51%
Follow BAX
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 7.41 | 0.00 | 33.53 | 37.15 | 41.40 | 21.65 | 50.89 | 4.91 |
Piotroski F-Score |
4 | 4 | 6 | 3 | 4 | 5 | 5 | 8 | 7 | 6 |
P/S ratio |
0.87 | 1.40 | 1.90 | 2.56 | 3.55 | 3.50 | 3.75 | 3.17 | 3.45 | 2.39 |
Altman Z-Score |
2.12 | 1.81 | 1.97 | 1.55 | 2.43 | 4.47 | 4.92 | 5.31 | 5.00 | 4.39 |
Altman Z″-Score (non-manufacturers) |
3.86 | 2.88 | 3.19 | 1.98 | 3.23 | 5.68 | 5.82 | 6.17 | 6.17 | 6.11 |
P/FCF ratio |
29.53 | 25.95 | 15.19 | 30.84 | 28.15 | 35.24 | 30.23 | 25.88 | 33.22 | 25.95 |
Beneish M-Score |
(2.67) | (2.76) | (2.94) | (3.32) | (2.23) | (2.56) | (2.74) | (2.59) | (2.73) | (1.27) |
P/Operating CF |
16.79 | 30.47 | 37.02 | 58.60 | 62.18 | 57.36 | 51.34 | 49.57 | 93.28 | 34.03 |
Dividend Safety Score |
0 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.61 | 2.12 | 2.32 | 4.36 | 4.72 | 4.68 | 5.38 | 4.47 | 4.00 | 2.93 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.64 | 12.48 | 10.18 | 7.86 | 5.30 |
EV/Sales |
1.54 | 2.47 | 2.93 | 4.04 | 4.76 | 3.71 | 3.92 | 3.32 | 3.46 | 2.39 |
EV/EBITDA |
11.96 | 17.65 | 17.94 | 29.39 | 26.07 | 17.63 | 17.20 | 15.62 | 17.95 | 15.69 |
EV/Operating CF |
20.49 | 25.74 | 17.58 | 33.56 | 26.01 | 23.18 | 21.19 | 18.24 | 21.35 | 14.66 |
EV/FCF |
52.15 | 45.78 | 23.44 | 48.73 | 37.75 | 37.36 | 31.66 | 27.09 | 33.33 | 25.93 |
Quick Ratio |
1.29 | 0.53 | 0.74 | 0.90 | 1.32 | 1.72 | 1.62 | 1.31 | 1.84 | 1.64 |
Current Ratio |
2.31 | 1.36 | 1.48 | 1.69 | 2.09 | 2.52 | 2.32 | 2.12 | 2.57 | 2.40 |
Net Debt/EBITDA |
5.19 | 7.65 | 6.31 | 10.79 | 6.63 | 1.00 | 0.78 | 0.70 | 0.06 | (0.01) |
Debt/Assets |
47.25% | 50.91% | 48.65% | 58.81% | 52.68% | 30.93% | 29.41% | 22.17% | 20.52% | 17.90% |
Debt/Equity |
1.55 | 1.87 | 1.62 | 2.82 | 1.94 | 0.71 | 0.68 | 0.44 | 0.39 | 0.34 |
Asset Turnover |
0.49 | 0.39 | 0.37 | 0.33 | 0.45 | 0.61 | 0.67 | 0.68 | 0.65 | 0.56 |
Operating CF/Net income |
(0.88) | (1.57) | 0.65 | (0.50) | 1.73 | 1.70 | 2.10 | 1.30 | 2.85 | 0.33 |
Capex/Depreciation |
(0.29) | (0.30) | (0.44) | (0.09) | (0.80) | (0.84) | (0.85) | (0.85) | (0.82) | (0.90) |
Interest Coverage |
(1.29) | 0.04 | 1.61 | (7.22) | 6.99 | 12.06 | 24.96 | 35.20 | 23.42 | 11.29 |
| (14.58%) | (8.38%) | 36.98% | (32.41%) | 14.39% | 13.25% | 12.69% | 18.21% | 6.92% | 57.92% | |
| (4.18%) | (2.40%) | 9.39% | (7.87%) | 4.80% | 5.77% | 5.90% | 9.42% | 3.69% | 27.20% | |
ROIC |
(1.41%) | 0.05% | 2.31% | (8.54%) | 3.54% | 9.03% | 11.16% | 10.41% | 8.72% | 5.64% |
Return on Tangible Assets |
(14.05%) | (12.45%) | 44.50% | (30.56%) | 13.08% | 11.24% | 11.39% | 20.14% | 6.67% | 61.15% |
Average Days of Receivables |
60.41 | 57.62 | 60.56 | 93.31 | 79.00 | 62.76 | 60.91 | 60.51 | 61.83 | 60.73 |
Research and Development Expense of Revenue |
4.61% | 5.55% | 5.00% | 4.47% | 4.37% | 4.46% | 5.24% | 5.89% | 5.81% | 6.36% |
Selling, General and Administrative Expense of Revenue |
25.70% | 27.90% | 28.50% | 30.79% | 23.42% | 21.15% | 22.31% | 23.61% | 24.82% | 26.81% |
Intangible Assets out of Total Assets |
0.46 | 0.41 | 0.41 | 0.47 | 0.53 | 0.24 | 0.25 | 0.28 | 0.26 | 0.24 |
Share Based Compensation of Revenue |
1.04% | 1.07% | 1.11% | 1.39% | 1.20% | 1.11% | 1.07% | 1.04% | 1.01% | 1.13% |
Graham Net Nets |
(0.72) | (0.67) | (0.52) | (0.56) | (0.36) | (0.07) | (0.07) | (0.05) | (0.02) | (0.03) |
Graham Number |
0.00 | 0.00 | 44.42 | 0.00 | 32.35 | 28.86 | 26.58 | 31.74 | 22.33 | 55.60 |
Earnings Yield |
(9.68%) | (4.39%) | 13.49% | (9.46%) | 2.98% | 2.69% | 2.42% | 4.62% | 1.97% | 20.39% |
Free Cash Flow Yield |
3.39% | 3.85% | 6.58% | 3.24% | 3.55% | 2.84% | 3.31% | 3.86% | 3.01% | 3.85% |
Revenue per Share |
21.92 | 20.85 | 20.47 | 19.95 | 24.20 | 22.93 | 22.32 | 20.78 | 19.49 | 18.61 |
Operating CF per Share |
1.65 | 2.00 | 3.41 | 2.40 | 4.43 | 3.67 | 4.13 | 3.78 | 3.16 | 3.03 |
Capex per Share |
(1.00) | (0.87) | (0.85) | (0.75) | (1.38) | (1.39) | (1.37) | (1.23) | (1.13) | (1.32) |
Free Cash Flow per Share |
0.65 | 1.12 | 2.56 | 1.65 | 3.05 | 2.28 | 2.77 | 2.54 | 2.02 | 1.71 |
Cash per Share |
3.83 | 3.46 | 6.08 | 3.41 | 5.88 | 7.33 | 6.55 | 3.44 | 6.25 | 5.13 |
Shareholders Equity per Share |
11.89 | 13.77 | 16.74 | 11.70 | 18.17 | 17.14 | 15.54 | 14.73 | 16.79 | 15.16 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.89 | 13.77 | 16.74 | 11.70 | 18.17 | 17.14 | 15.54 | 14.73 | 16.79 | 15.16 |
Free Cash Flow |
332.00 | 573.00 | 1,294.00 | 834.00 | 1,531.00 | 1,159.00 | 1,408.00 | 1,358.00 | 1,098.00 | 935.00 |
Working Capital |
3,902.00 | 2,342.00 | 3,097.00 | 3,266.00 | 4,636.00 | 5,078.00 | 4,273.00 | 3,145.00 | 4,442.00 | 3,830.00 |
Capital Expenditures |
(513.00) | (446.00) | (432.00) | (377.00) | (691.00) | (709.00) | (696.00) | (659.00) | (616.00) | (719.00) |
Net Current Asset Value |
(7,081.00) | (9,905.00) | (10,208.00) | (14,381.00) | (15,528.00) | (2,882.00) | (2,778.00) | (1,895.00) | (732.00) | (692.00) |
EV/EBIT |
0.00 | 1,873.83 | 42.91 | 0.00 | 42.82 | 26.80 | 25.16 | 23.23 | 28.41 | 32.54 |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 |
Price to Operating Income |
0.00 | 1,062.26 | 27.81 | 0.00 | 31.92 | 25.27 | 24.02 | 22.19 | 28.32 | 32.57 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.60 | 0.51 | 0.34 | 0.90 | 0.17 | 0.18 | 0.18 | 0.17 | 0.16 | 0.19 |
Cash ROIC |
1.89% | 2.61% | 5.11% | 3.44% | 5.15% | 6.22% | 8.48% | 10.30% | 6.85% | 6.74% |
Accounts Receivable Turnover |
6.35 | 6.26 | 4.83 | 3.87 | 5.24 | 5.98 | 6.08 | 6.11 | 6.08 | 5.94 |
Accounts Payable Turnover |
8.00 | 7.20 | 6.24 | 5.52 | 6.49 | 3.80 | 2.40 | 2.29 | 2.29 | 2.29 |
Inventory Turnover |
3.68 | 3.36 | 2.70 | 2.54 | 3.40 | 3.97 | 3.98 | 4.04 | 4.21 | 3.99 |
Average Days of Payables |
46.36 | 53.11 | 51.78 | 62.25 | 61.24 | 53.73 | 148.69 | 161.77 | 163.26 | 157.66 |
Days of Inventory on Hand |
103.58 | 112.27 | 112.73 | 150.25 | 120.57 | 98.69 | 91.40 | 95.97 | 88.11 | 86.32 |
Average Receivables |
1,770.00 | 1,699.00 | 2,145.00 | 2,600.00 | 2,318.00 | 1,951.50 | 1,868.00 | 1,816.50 | 1,742.00 | 1,711.00 |
Average Payables |
983.50 | 924.50 | 995.50 | 1,178.00 | 1,144.50 | 1,866.00 | 2,749.50 | 2,771.50 | 2,672.50 | 2,639.00 |
Average Inventory |
2,139.00 | 1,982.00 | 2,298.50 | 2,566.00 | 2,184.50 | 1,784.50 | 1,660.00 | 1,571.00 | 1,452.50 | 1,517.00 |
Average Assets |
22,918.50 | 27,029.00 | 28,281.50 | 30,904.00 | 26,770.00 | 19,106.00 | 16,956.50 | 16,415.50 | 16,328.50 | 18,254.00 |
Average Common Equity |
6,563.00 | 7,746.00 | 7,181.50 | 7,508.00 | 8,923.50 | 8,319.00 | 7,889.00 | 8,491.00 | 8,698.00 | 8,572.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026